drugset / Trial / NCT06897917
Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain
NaSingle-groupOpen-labelTreatment
Summary
This study is a prospective, single-arm, multicenter, real-world study to evaluate effect of bowel function, analgesic effect, quality of life, and safety of Mimeixin® in Chinese patients with severe cancer pain.
Timeline
- Start
- 2025-04
- Primary completion
- 2025-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naloxone | Small molecule | 2.5 mg | — |
| Subject | Naloxone | Small molecule | 5 mg | — |
| Subject | Oxycodone | Other / unclassified | 5 mg | — |
| Subject | Oxycodone | Other / unclassified | 10 mg | — |